Genetic analysis and multimodal imaging identify novel mtDNA 12148T>C leading to multisystem dysfunction with tissue-specific heteroplasmy

• Published in: medRxiv : the preprint server for health sciences
• Main Authors: Belle, Kinsley, Kreymerman, Alexander, Vadgama, Nirmal, Ji, Marco H, Randhawa, Sandeep, Caicedo, Juan, Wong, Megan, Muscat, Stephanie P, Gifford, Casey A, Lee, Richard T, Nasir, Jamal, Young, Jill L, Enns, Gregory, Karakikes, Ioannis, Mercola, Mark, Wood, Edward H
• Format: Journal Article
• Language: English
• Published: United States 05.11.2023

Patients with mitochondrial disorders present with clinically diverse symptoms, largely driven by heterogeneous mutations in mitochondrial-encoded and nuclear-encoded mitochondrial genes. These mutations ultimately lead to complex biochemical disorders with a myriad of clinical manifestations, often accumulating during childhood on into adulthood, contributing to life-altering and sometimes fatal events. It is therefore important to diagnose and characterize the associated disorders for each mitochondrial mutation as early as possible since medical management might be able to improve the quality and longevity of life in mitochondrial disease patients. Here we identify a novel mitochondrial variant in a mitochondrial transfer RNA for histidine (mt-tRNA-his) [m.12148T>C], that is associated with the development of ocular, aural, neurological, renal, and muscular dysfunctions. We provide a detailed account of a family harboring this mutation, as well as the molecular underpinnings contributing to cellular and mitochondrial dysfunction. In conclusion, this investigation provides clinical, biochemical, and morphological evidence of the pathogenicity of m.12148T>C. We highlight the importance of multiple tissue testing and in vitro disease modeling in diagnosing mitochondrial disease.